Janssen Presents First Data from MajesTEC-2 Trial of TECVAYLI ™ (teclistamab-cqyv) in Combination with DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) and Lenalidomide in Relapsed or Refractory Multiple Myeloma
NEW ORLEANS, December 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new results from a cohort of the Phase 1b MajesTEC-2 study of TECVAYLI™ (teclistamab-cqyv), a first-in-class, BCMAxCD3 bispecific T-cell engager antibody, in combination with DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) and lenalidomide. According to the results, the immune-based triplet therapy regimen had a manageable safety profile with no unexpected safety signals observed. A very good partial response (VGPR) or better was achieved by 90.3 percent of patients with relapsed or refractory multiple ...
Source: Johnson and Johnson - December 10, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

Janssen Presents New Data for Talquetamab, a First-in-Class GPRC5DxCD3 Bispecific Antibody, Suggesting Durable Responses in Patients with Heavily Pretreated Multiple Myeloma
NEW ORLEANS, December 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today updated results from the Phase 1/2 MonumenTAL-1 study of talquetamab, an investigational, off-the-shelf (ready to use), bispecific T-cell engager antibody. Talquetamab targets both GPRC5D, a novel target on multiple myeloma cells, and CD3 on T cells, activating the body’s immune system to fight this blood cancer.[1] Results from the study suggest patients with relapsed or refractory multiple myeloma who received a median of five prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agen...
Source: Johnson and Johnson - December 10, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

New Results from the Phase 3 GLOW Study of Fixed-Duration Treatment with IMBRUVICA ® (ibrutinib) Plus Venetoclax Demonstrate Robust Efficacy and Sustained Response in Older, Unfit Patients with Previously Untreated Chronic Lymphocytic Leukemia
NEW ORLEANS, December 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new four-year follow-up results from the Phase 3 GLOW study (Abstract #93), which showed investigational, fixed-duration treatment with IMBRUVICA® + venetoclax (I+V) reduced the risk of progression or death by 79 percent among older and/or unfit patients with previously untreated chronic lymphocytic leukemia (CLL) compared to patients treated with chemoimmunotherapy.[i] These results were highlighted in an oral presentation during the 2022 American Society of Hematology (ASH) Annual Meeting.1CLL is the most com...
Source: Johnson and Johnson - December 10, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

Janssen Submits Biologics License Application to U.S. FDA for Talquetamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
RARITAN, N.J., December 9, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for talquetamab for the treatment of patients with relapsed or refractory multiple myeloma. Talquetamab is an investigational, off-the-shelf (ready to use), bispecific T-cell engager antibody targeting both GPRC5D, a novel drug target that is on some normal cells but overexpressed on myeloma cells, and separately targets CD3 on T cells.[1]“Despite the therapies that have been developed for the treatment of m...
Source: Johnson and Johnson - December 9, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

Regulatory update: Radiology faces revenue cuts in 2023
Unless Congress acts again at the last minute, Medicare reimbursement cuts wil...Read more on AuntMinnie.comRelated Reading: Expanded authorization for nonphysician providers Top 3 threats to independent radiology practices What will the MIPS Value Pathways option mean for radiology? Coding and documentation for arterial embolization How will the MPFS proposed rule valuation changes impact radiology?
Source: AuntMinnie.com Headlines - December 5, 2022 Category: Radiology Source Type: news

What is the Current Classification for Ehlers-Danlos Syndrome?
Discussion As with any potential problem there is a often a range from normal to abnormal and this is true for joint hypermobility. Generalized joint hypermobility is hypermobility in multiple joints with few or no other symptoms. Generalized hypermobility spectrum disorder (also known as joint hypermobility syndrome) has hypermobility along with other symptoms such as pain, reduced muscle strength, and decreased proprioception and balance. Other clinical entities with hypermobility include Ehlers-Danlos syndrome, Marfan syndrome, and osteogenesis imperfecta. In the office, a 5-point questionnaire with 2 or more “yes...
Source: PediatricEducation.org - December 5, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

How Roblox built a hiring test that feels like a video game
Ritti Bhogal had never seen an internship test like this before. “It was like a game,” says the second-year NYU student of her recent experience taking an online Roblox exam. She had guessed it would involve coding and take place on the Roblox platform, which attracts around 40 million daily…#robloxctodansturman #rittibhogal #google #scimold #mars #nyu #codesignal #sat #deepayamsanyal #davidbaszucki
Source: Reuters: Health - December 4, 2022 Category: Consumer Health News Source Type: news

VW Looks to Expand Coding Schools to Bolster Tech Skills
Bloomberg#vwlooks #bolstertechskillsbloomberg
Source: Reuters: Health - December 3, 2022 Category: Consumer Health News Source Type: news

Sources: BloomTech, previously Lambda School, is cutting half of staff, or an estimated 88 employees, its third round of known layoffs since the pandemic began
A little over a year after buzzy coding bootcamp Lambda School rebranded as Bloom Institute of Technology, the venture-backed startup is conducting massive layoffs, according to sources. The workforce reduction, per people familiar with the matter, has impacted half of the company’s staff across…#bloominstituteoftechnology #austenallred #allred #careerkarma #bloomtech #flockjay #lambdaschool
Source: Reuters: Health - December 2, 2022 Category: Consumer Health News Source Type: news

How to Automate WhatsApp Messaging for Small Businesses for Free
How to Automate Bulk WhatsApp Messaging without coding? Anyone can automate Bulk WhatsApp Messaging and the requirements are simple: WhatsApp Desktop App, Excel and Power Automate (which comes pre-installed with Windows 11). It is a fairly simple process and takes less than 15 minutes to…#googlechrome #connectingexcel #save #google #whatsappmessages #chrome #edge #whatsapp #thedocumentpath #clickonsave
Source: Reuters: Health - December 2, 2022 Category: Consumer Health News Source Type: news

BloomTech, previously Lambda School, cuts half of staff
A little over a year after buzzy coding bootcamp Lambda School rebranded as Bloom Institute of Technology, the venture-backed startup is conducting massive layoffs, according to sources. The workforce reduction, per people familiar with the matter, has impacted half of the company’s staff across…#natashamascarenhas #bloominstituteoftechnology #techcrunch #lambdaschool #bloomtech #austinallred #businessinsider #flockjay #allred #careerkarma
Source: Reuters: Health - December 1, 2022 Category: Consumer Health News Source Type: news

Coding quality of global elderly fall mortality data and its impact, 1990-2019 conference abstract #101 - Hua J, Ning P, Cheng P, Rao Z, He J, Xiao W, Li L, Fu Y, Li R, Li J, Wang W, Schwebel DC, Hu G.
Proceedings of the 14th World Conference on Injury Prevention and Safety Promotion (Safety 2022) Background To assess the coding quality of deaths and its impact on elderly unintentional fall mortality. Methods Using data from the World Health Organ...
Source: SafetyLit - November 30, 2022 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Application of a machine learning-based decision support tool in injury surveillance system conference abstract #391 - Catchpoole J, Nanda G, Vallmuur K, Nand G, Lehto M.
Proceedings of the 14th World Conference on Injury Prevention and Safety Promotion (Safety 2022) Background Emergency department (ED)-based injury surveillance systems across many countries face resourcing challenges related to the validation and coding...
Source: SafetyLit - November 30, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Coding unpaid carers
NHS England recently shared guidance and an accompanying letter to support the consistent use of SNOMED CT codes for reporting unpaid carer status in primary care records.
Source: NHS Networks - November 25, 2022 Category: UK Health Source Type: news

CMS: Medicare and Medicaid Programs; CY 2023 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Implementing Requirements for Manufacturers of Certain Single-dose Container or Single-use Package Drugs To Provide Refunds With Respect to Discarded Amounts; and COVID-19 Interim Final Rules
Notice of final rule from the Centers for Medicare& Medicaid Services (CMS) making changes to the following: 1) Physician Fee Schedule and Medicare Part B payment policies; 2) Medicare Shared Savings Program requirements; 3) updates to the Quality Payment Program; 4) Medicare coverage of opioid use disorder services furnished by opioid treatment programs; 5) updates to certain Medicare and Medicaid provider enrollment policies; 6) updates to conditions of payment for DMEPOS suppliers; 7) coding and payment for wound care management product; 8) requirements for electronic prescribing for controlled substances for a covered ...
Source: Federal Register updates via the Rural Assistance Center - November 18, 2022 Category: Rural Health Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20